Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

After the publication of the revised edition, therapeutic drugs described in “Future Treatment”
were approved and important evidence for pharmacologic therapy and nonpharmacologic …

ABSTRACT Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Background Traditional approaches to guideline-directed medical therapy (GDMT)
management often lead to delayed initiation and titration of therapies in patients with heart …

Abstract The American College of Cardiology/American Heart Association/Heart Failure
Society of American 2022 guidelines for heart failure (HF) recommend a multidisciplinary …

Aims Patients with heart failure (HF) have poor outcomes, including poor quality of life, and
high morbidity and mortality. In addition, they have a high medication burden due to the …

Objective To undertake a synthesis of evidence-based research for seven innovative models
of care to inform the development of new hospitals. Design Umbrella review. Setting …

Background Integrated care is a model recognised internationally, however, there is limited
evidence about its usability in the community. This study aimed to elicit community and …

Purpose As insufficient adherence to recommendations is a major cause of poor health
outcomes in patients with heart failure (HF), it is important to identify the factors that improve …

Heart failure (HF) patients tend to have multiple comorbidities resulting in complex therapy
regimens and medication adherence issues. Nevertheless, the evidence of pharmacists' …